Postoperative morbidity following Hartmann's procedure in comparison to anterior resection and abdominoperineal resection for rectal cancer-a population-based study.

Autor: Mariusdottir E; Department of Surgery, Helsingborg Hospital, Helsingborg, Sweden.; Lund University, Lund, Sweden., Jörgren F; Department of Surgery, Helsingborg Hospital, Helsingborg, Sweden.; Lund University, Lund, Sweden., Lydrup ML; Lund University, Lund, Sweden.; Department of Surgery, Skåne University Hospital, Malmö, Sweden., Buchwald P; Lund University, Lund, Sweden.; Department of Surgery, Skåne University Hospital, Malmö, Sweden.
Jazyk: angličtina
Zdroj: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland [Colorectal Dis] 2024 Jun; Vol. 26 (6), pp. 1250-1257. Date of Electronic Publication: 2024 May 27.
DOI: 10.1111/codi.17033
Abstrakt: Aim: There is ongoing controversy regarding the extent to which Hartmann's procedure (HP) should be used in rectal cancer treatment. This study was designed to investigate 30-day postoperative morbidity and mortality following HP, anterior resection (AR) and abdominoperineal resection (APR) for rectal cancer using a national registry.
Methods: All patients operated for rectal cancer, tumour height 5-15 cm, between the years 2010 and 2017, were identified through the Swedish colorectal cancer registry.
Results: A total of 8476 patients were included: 1210 (14%) undergoing HP, 5406 (64%) AR and 1860 (22%) APR. HP was associated with an increased risk of intra-abdominal infection (OR 1.7, CI 1.26-2.28, P = 0.0004) compared to AR and APR, while APR was related to an increased risk of overall complications (OR 1.18, CI 1.01-1.40, P = 0.040). No significant difference was observed in the rate of reoperations and readmissions between HP, AR and APR, and type of surgical procedure was not a risk factor for 30-day mortality. Findings from a subgroup analysis of patients with a tumour 5-7 cm from the anal verge revealed that HP was not associated with increased risk for complications or 30-day mortality.
Conclusions: For patients where AR is not appropriate HP is a valid alternative with a favourable outcome. APR was associated with the highest overall 30-day complication rate.
(© 2024 The Author(s). Colorectal Disease published by John Wiley & Sons Ltd on behalf of Association of Coloproctology of Great Britain and Ireland.)
Databáze: MEDLINE
Externí odkaz: